Markets › India › NSE › MARKSANS

Marksans Pharma Ltd

NSE:MARKSANSHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹303.05−2.56%At closeAt close · Mon 19 Oct · ≈ AED 11.69 · Market cap $1.48B · Next earnings Thu 5 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	54.8%	49.5%	50.3%	50.7%	56.4%	39.2%	—	—
Operating margin	40.1%	34.9%	16.2%	17.8%	43.0%	17.1%	17.1%	+0.0 pts
Net margin	17.4%	12.5%	14.4%	14.4%	14.5%	14.2%	14.2%	+0.0 pts
EBITDA margin	25.3%	20.3%	21.5%	23.4%	20.2%	20.4%	—	—
Return on equity	26.9%	15.4%	15.3%	15.2%	15.4%	13.8%	13.7%	−0.1 pts
Return on assets	19.4%	11.3%	12.2%	11.7%	11.7%	10.8%	10.8%	+0.0 pts
Return on capital employed	58.9%	40.3%	16.2%	16.9%	40.9%	15.1%	—	—
Debt / equity	0.0×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	−1.0%
Debt / assets	2.8%	6.8%	5.6%	9.1%	9.9%	8.9%	—	—
Interest coverage	68.6×	61.2×	32.8×	34.6×	96.8×	20.9×	—	—
Current ratio	3.0×	3.4×	4.9×	4.8×	4.6×	5.2×	5.2×	+0.0%
Quick ratio	1.7×	2.2×	3.5×	3.2×	2.8×	3.3×	—	—
Cash ratio	0.7×	1.0×	1.1×	1.0×	1.0×	1.9×	1.9×	+0.0%
Asset turnover	1.1×	0.9×	0.8×	0.8×	0.8×	0.8×	—	—
Inventory turnover	1.5×	1.8×	1.9×	1.7×	1.4×	1.8×	—	—
Receivables turnover	5.0×	3.7×	4.4×	4.7×	4.8×	4.6×	—	—
Dividend payout	1.7%	5.7%	3.8%	7.2%	7.1%	8.7%	—	—